Bone marrow stromal cells improved functional recovery in spinal cord injury rats partly via the Toll‑like receptor‑4/nuclear factor‑κB signaling pathway

Bai,Shi; Zhou,Hao; Wu,Lijuan

doi:10.3892/etm.2018.6907

Bone marrow stromal cells improved functional recovery in spinal cord injury rats partly via the Toll‑like receptor‑4/nuclear factor‑κB signaling pathway

Authors:
- Shi Bai
- Hao Zhou
- Lijuan Wu
View Affiliations

Affiliations: Department of Anatomy, School of Medicine, Taizhou University, Taizhou, Zhejiang 317000, P.R. China, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, P.R. China
Published online on: October 31, 2018 https://doi.org/10.3892/etm.2018.6907
Pages: 444-448

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Spinal cord injury (SCI) results in inflammation, and TLR4, which is an inflammatory factor, has an important role in the pathological injury that occurs following SCI. Recently, bone marrow stromal cells (BMSCs) have been demonstrated to be a novel treatment in SCI. However, the underlying mechanism of neuroprotection in SCI by BMSCs remains unclear. The present study was designed to investigate the therapeutic mechanism of BMSCs in SCI by analysis of Toll‑like receptor 4 (TLR4)/nuclear factor‑κB (NF‑κB) expression. The present results demonstrated that BMSC transplantation promoted functional recovery and tissue repair in SCI rats. Interestingly, it also reduced the expression of TLR4 and NF‑κB after SCI. Furthermore, it was demonstrated that BMSCs downregulated the expression of apoptosis factor caspase‑12 in the SCI rat model. The present results demonstrated that BMSCs may have incorporated into the spinal cord to improve locomotor function after SCI, partly via the TLR4/NF‑κB signaling pathway. To the best of our knowledge, this is the first study to determine that BMSCs prevented secondary injury and enhanced functional recovery in SCI via inhibition of TLR4/NF‑κB‑mediated inflammation.

View Figures

View References

1	Rubiano AM, Carney N, Chesnut R and Puyana JC: Global neurotrauma research challenges and opportunities. Nature. 527:S193–S197. 2015. View Article : Google Scholar : PubMed/NCBI
2	Allison DJ and Ditor DS: Immune dysfunction and chronic inflammation following spinal cord injury. Spinal Cord. 53:14–18. 2015. View Article : Google Scholar : PubMed/NCBI
3	Orr MB, Simkin J, Bailey WM, Kadambi NS, McVicar AL, Veldhorst AK and Gensel JC: Compression Decreases Anatomical and Functional Recovery and Alters Inflammation after Contusive Spinal Cord Injury. J Neurotrauma. 34:2342–2352. 2017. View Article : Google Scholar : PubMed/NCBI
4	Okada S: The pathophysiological role of acute inflammation after spinal cord injury. Inflamm Regen. 36:202016. View Article : Google Scholar : PubMed/NCBI
5	Lin L, Lin H, Bai S, Zheng L and Zhang X: Bone marrow mesenchymal stem cells (BMSCs) improved functional recovery of spinal cord injury partly by promoting axonal regeneration. Neurochem Int. 115:80–84. 2018. View Article : Google Scholar : PubMed/NCBI
6	Pu Y, Meng K, Gu C, Wang L and Zhang X: Thrombospondin-1 modified bone marrow mesenchymal stem cells (BMSCs) promote neurite outgrowth and functional recovery in rats with spinal cord injury. Oncotarget. 8:96276–96289. 2017. View Article : Google Scholar : PubMed/NCBI
7	Gu C, Li H, Wang C, Song X, Ding Y, Zheng M, Liu W, Chen Y, Zhang X and Wang L: Bone marrow mesenchymal stem cells decrease CHOP expression and neuronal apoptosis after spinal cord injury. Neurosci Lett. 636:282–289. 2017. View Article : Google Scholar : PubMed/NCBI
8	Tang X, Chen F, Lin Q, You Y, Ke J and Zhao S: Bone marrow mesenchymal stem cells repair the hippocampal neurons and increase the expression of IGF-1 after cardiac arrest in rats. Exp Ther Med. 14:4312–4320. 2017.PubMed/NCBI
9	Zhang L, Chen J, Chai W, Ni M, Sun X and Tian D: Glycitin regulates osteoblasts through TGF-β or AKT signaling pathways in bone marrow stem cells. Exp Ther Med. 12:3063–3067. 2016. View Article : Google Scholar : PubMed/NCBI
10	Zheng YH, Deng YY, Lai W, Zheng SY, Bian HN, Liu ZA, Huang ZF, Sun CW, Li HH, Luo HM, et al: Effect of bone marrow mesenchymal stem cells on the polarization of macrophages. Mol Med Rep. 17:4449–4459. 2018.PubMed/NCBI
11	Ock SA, Baregundi Subbarao R, Lee YM, Lee JH, Jeon RH, Lee SL, Park JK, Hwang SC and Rho GJ: Comparison of Immunomodulation Properties of Porcine Mesenchymal Stromal/Stem Cells Derived from the Bone Marrow, Adipose Tissue, and Dermal Skin Tissue. Stem Cells Int. 2016:95813502016. View Article : Google Scholar : PubMed/NCBI
12	Ide C, Nakai Y, Nakano N, Seo TB, Yamada Y, Endo K, Noda T, Saito F, Suzuki Y, Fukushima M, et al: Bone marrow stromal cell transplantation for treatment of sub-acute spinal cord injury in the rat. Brain Res. 1332:32–47. 2010. View Article : Google Scholar : PubMed/NCBI
13	Hawryluk GW, Mothe A, Wang J, Wang S, Tator C and Fehlings MG: An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev. 21:2222–2238. 2012. View Article : Google Scholar : PubMed/NCBI
14	Yang W, Yang Y, Yang JY, Liang M and Song J: Treatment with bone marrow mesenchymal stem cells combined with plumbagin alleviates spinal cord injury by affecting oxidative stress, inflammation, apoptotis and the activation of the Nrf2 pathway. Int J Mol Med. 37:1075–1082. 2016. View Article : Google Scholar : PubMed/NCBI
15	Cho SR, Kim YR, Kang HS, Yim SH, Park CI, Min YH, Lee BH, Shin JC and Lim JB: Functional Recovery after the Transplantation of Neurally Differentiated Mesenchymal Stem Cells Derived from Bone Marrow in a Rat Model of Spinal Cord Injury. Cell Transplant. 25:14232016. View Article : Google Scholar : PubMed/NCBI
16	Lester SN and Li K: Toll-like receptors in antiviral innate immunity. J Mol Biol. 426:1246–1264. 2014. View Article : Google Scholar : PubMed/NCBI
17	Kigerl KA and Popovich PG: Toll-like receptors in spinal cord injury. Curr Top Microbiol Immunol. 336:121–136. 2009.PubMed/NCBI
18	Heiman A, Pallottie A, Heary RF and Elkabes S: Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord. Brain Behav Immun. 42:232–245. 2014. View Article : Google Scholar : PubMed/NCBI
19	Ntoufa S, Vilia MG, Stamatopoulos K, Ghia P and Muzio M: Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies. Semin Cancer Biol. 39:15–25. 2016. View Article : Google Scholar : PubMed/NCBI
20	Liu J, Wang Y and Ouyang X: Beyond toll-like receptors: Porphyromonas gingivalis induces IL-6, IL-8, and VCAM-1 expression through NOD-mediated NF-κB and ERK signaling pathways in periodontal fibroblasts. Inflammation. 37:522–533. 2014. View Article : Google Scholar : PubMed/NCBI
21	Zhou R, Alvarado L, Ogilvie R, Chong SL, Shaw O and Mushahwar VK: Non-gait-specific intervention for the rehabilitation of walking after SCI: Role of the arms. J Neurophysiol. 119:2194–2211. 2018. View Article : Google Scholar : PubMed/NCBI
22	Kong X and Gao J: Macrophage polarization: A key event in the secondary phase of acute spinal cord injury. J Cell Mol Med. 21:941–954. 2017. View Article : Google Scholar : PubMed/NCBI
23	Zhou Z, Liu C, Chen S, Zhao H, Zhou K, Wang W, Yuan Y, Li Z, Guo Y, Shen Z, et al: Activation of the Nrf2/ARE signaling pathway by probucol contributes to inhibiting inflammation and neuronal apoptosis after spinal cord injury. Oncotarget. 8:52078–52093. 2017.PubMed/NCBI
24	Fu Q, Li C and Yu L: Gambogic acid inhibits spinal cord injury and inflammation through suppressing the p38 and Akt signaling pathways. Mol Med Rep. 17:2026–2032. 2018.PubMed/NCBI
25	Yuan B, Liu D and Liu X: Spinal cord stimulation exerts analgesia effects in chronic constriction injury rats via suppression of the TLR4/NF-κB pathway. Neurosci Lett. 581:63–68. 2014. View Article : Google Scholar : PubMed/NCBI
26	He Z, Zhou Y, Lin L, Wang Q, Khor S, Mao Y, Li J, Zhen Z, Chen J, Gao Z, et al: Dl-3-n-butylphthalide attenuates acute inflammatory activation in rats with spinal cord injury by inhibiting microglial TLR4/NF-κB signalling. J Cell Mol Med. 21:3010–3022. 2017. View Article : Google Scholar : PubMed/NCBI
27	Chen X, Chen X, Huang X, Qin C, Fang Y, Liu Y, Zhang G, Pan D, Wang W and Xie M: Soluble epoxide hydrolase inhibition provides multi-target therapeutic effects in rats after spinal cord injury. Mol Neurobiol. 53:1565–1578. 2016. View Article : Google Scholar : PubMed/NCBI